Erythrophagocytosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin

被引:34
作者
Beaumont, C [1 ]
Canonne-Hergaux, F [1 ]
机构
[1] Fac Xavier Bichat, INSERM, U656, 16 Rue Henri Huchard, F-75018 Paris, France
关键词
macrophage; phagocytosis; red blood cells; senescence; heme; iron; hepcidin; ferropportin;
D O I
10.1016/j.tracli.2005.04.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most of the iron required for erythropoiesis is provided by heme iron recycling following degradation of senescent erythrocytes by tissue macrophages. Accumulation of biochemical modifications at the red blood cell membrane during ageing (externalisation of phosphatidylserine, peroxydation of membrane-bound lipoproteins, loss of sialic acid residues and formation of senescence neoantigens) constitute a series of signals that will allow the macrophage to identify the red blood cells to be eliminated, through interaction with specific receptors. After this initial recognition step, the red blood cell is internalised by phagocytosis, and phagosome maturation, which can comprise recruitment of the endoplasmic reticulum, will favour degradation of red blood cell constituents. Heme is catabolised by heme oxygenase 1, anchored in the endoplasmic reticulum membrane. A fraction of the released iron will be recycled back to the plasma through ferroportin, a membrane-bound Fe (II) export molecule, and a fraction will retained within the ferritin molecules, to be released at later stages. Multiple evidence coming from human diseases (type 4 hemochromatosis) and animal models indicate that ferroportin is essential for heme iron recycling by macrophages. Furthermore, ferroportin seems to be the molecular target of hepcidin, this circulating peptide synthesized by the liver and acting as a negative regulator of intestinal iron absorption and iron recycling by macrophages. Perturbations in erythrophagocytosis play a physiopathological role in several diseases, including hemochromatosis, anemia of chronic disorders and thalassemia. (c) 2005 Elsevier SAS. Tons droits reserves.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 41 条
  • [31] The ferroportin disease
    Pietrangelo, A
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) : 131 - 138
  • [32] Heme oxygenase 1 is required for mammalian iron reutilization
    Poss, KD
    Tonegawa, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10919 - 10924
  • [33] Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
    Roetto, A
    Papanikolaou, G
    Politou, M
    Alberti, F
    Girelli, D
    Christakis, J
    Loukopoulos, D
    Camaschella, C
    [J]. NATURE GENETICS, 2003, 33 (01) : 21 - 22
  • [34] SCHACTER BA, 1988, SEMIN HEMATOL, V25, P349
  • [35] Pathophysiology of thalassemia
    Schrier, SL
    [J]. CURRENT OPINION IN HEMATOLOGY, 2002, 9 (02) : 123 - 126
  • [36] VIATTE L, 2005, BLOOD
  • [37] Pathogenesis and treatment of anaemia of chronic disease
    Weiss, G
    [J]. BLOOD REVIEWS, 2002, 16 (02) : 87 - 96
  • [38] Aceruloplasminemia - An inherited neurodegenerative disease with impairment of iron homeostasis
    Xu, XY
    Pin, S
    Gathinji, M
    Fuchs, R
    Harris, ZL
    [J]. REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 : 299 - 305
  • [39] YANG F, 2005, AM J PHYSL LUNG CELL
  • [40] Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation
    Yang, FM
    Liu, XB
    Quinones, M
    Melby, PC
    Ghio, A
    Haile, DJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39786 - 39791